{
  "id": "mineralocorticoid",
  "title": "Mineralocorticoid",
  "lang": "en",
  "source_lang": "en",
  "summary": "Mineralocorticoids are steroid hormones that regulate sodium and potassium balance, extracellular fluid volume, and blood pressure, chiefly through actions on the kidneys.",
  "category": "health",
  "subcategory": "anatomy-physiology",
  "type": "concept",
  "aliases": [
    "Mineralocorticoid hormone",
    "Mineralocorticosteroid"
  ],
  "generated_at": "2026-11-06",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/mineralocorticoid/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/mineralocorticoid/",
      "json": "https://aiwiki.page/zh/mineralocorticoid.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "Mineralocorticoids are a class of corticosteroid hormones that regulate electrolyte balance and extracellular fluid volume. Their principal naturally occurring representative in humans is aldosterone, produced in the outer layer of the adrenal cortex. Mineralocorticoids act mainly on the kidneys, promoting sodium reabsorption and potassium excretion and thereby contributing to blood-pressure regulation and fluid homeostasis. The term also encompasses synthetic drugs with similar biological activity."
    },
    {
      "heading": "Classification and production",
      "text": "Corticosteroids are conventionally divided into mineralocorticoids and glucocorticoids. Mineralocorticoids are named for their effects on mineral electrolytes, particularly sodium and potassium; glucocorticoids are associated primarily with metabolic, stress-response, and immune effects. This distinction is functional rather than absolute: some corticosteroids have activity in both categories.\n\nAldosterone is synthesized from cholesterol in the zona glomerulosa, the outermost layer of the adrenal cortex. Its final biosynthetic steps depend on aldosterone synthase, an enzyme encoded by the CYP11B2 gene. Unlike hormones stored in secretory vesicles, adrenal steroid hormones are largely synthesized as needed and then released into the circulation.\n\nDeoxycorticosterone, a steroid precursor in adrenal hormone synthesis, also has mineralocorticoid activity. Although less important than aldosterone under normal conditions, excess production can cause clinically significant sodium retention and potassium loss."
    },
    {
      "heading": "Regulation of secretion",
      "text": "Aldosterone production is controlled chiefly by the renin–angiotensin–aldosterone system and the concentration of potassium in the blood.\n\n- Renin–angiotensin signaling: reduced renal perfusion, reduced sodium chloride delivery to the macula densa, or increased sympathetic stimulation can promote renin release. The resulting formation of angiotensin II stimulates aldosterone synthesis.\n- Potassium: increased extracellular potassium directly stimulates zona glomerulosa cells, increasing aldosterone secretion and facilitating renal potassium elimination.\n- Adrenocorticotropic hormone: this pituitary hormone can stimulate aldosterone secretion, but its effect is generally more transient and less important for sustained regulation than angiotensin II and potassium.\n\nFeedback through changes in circulating volume, renal perfusion, and potassium concentration helps coordinate secretion with physiological requirements."
    },
    {
      "heading": "Mechanism of action",
      "text": "Mineralocorticoids act chiefly through the mineralocorticoid receptor, an intracellular receptor that regulates gene expression. In the aldosterone-sensitive distal nephron, receptor activation increases the activity and abundance of proteins involved in sodium transport.\n\nIn principal cells of the late distal nephron and collecting duct, aldosterone promotes epithelial sodium-channel activity at the urine-facing membrane and sodium–potassium ATPase activity at the blood-facing membrane. Sodium is reabsorbed from tubular fluid into the body, while conditions favoring potassium secretion are enhanced. Aldosterone also promotes hydrogen-ion secretion by intercalated cells, contributing to acid–base regulation.\n\nThe receptor also binds cortisol, which circulates at much higher concentrations than aldosterone. In aldosterone-sensitive epithelia, the enzyme 11β-hydroxysteroid dehydrogenase type 2 converts cortisol to cortisone, which has little activity at the receptor. This local inactivation allows aldosterone-selective signaling despite the receptor’s affinity for both hormones.\n\nMineralocorticoid receptors are also present in the heart, blood vessels, brain, and other tissues. Their effects therefore extend beyond renal electrolyte handling, although these effects depend on tissue context and are not all attributable to aldosterone alone."
    },
    {
      "heading": "Physiological effects",
      "text": "The principal effects of mineralocorticoid action are:\n\n- Sodium conservation, supporting extracellular fluid volume.\n- Potassium excretion, helping maintain potassium balance.\n- Hydrogen-ion excretion, contributing to acid–base balance.\n- Support of blood pressure, through effects on sodium balance, circulating volume, and vascular function.\n\nWater retention is an indirect consequence of sodium conservation and depends on water availability, antidiuretic hormone activity, and other renal mechanisms. Mineralocorticoid action does not necessarily produce a rise in blood sodium concentration.\n\nAldosterone also affects electrolyte transport in the colon, sweat glands, and salivary glands."
    },
    {
      "heading": "Disorders of mineralocorticoid function",
      "text": "Excess activity\n\nPrimary aldosteronism involves aldosterone production that is inappropriate for the body’s regulatory state, commonly associated with unilateral adrenal disease or bilateral adrenal overproduction. It typically causes hypertension with suppressed renin. Potassium may be low, but normal potassium does not exclude the condition.\n\nSecondary aldosteronism results from activation of the renin–angiotensin system. It can occur with reduced renal perfusion or reduced effective arterial blood volume, including in some forms of heart failure and cirrhosis.\n\nExcess mineralocorticoid action can cause potassium depletion and metabolic alkalosis. Similar effects may occur without elevated aldosterone: impaired cortisol inactivation, including inhibition of 11β-hydroxysteroid dehydrogenase type 2 by compounds derived from liquorice, can allow cortisol to activate mineralocorticoid receptors.\n\nDeficiency or resistance\n\nInsufficient aldosterone production can occur in primary adrenal insufficiency or in disorders involving reduced renin production. It may cause potassium retention, impaired acid excretion, and, depending on the cause and severity, sodium loss and low blood pressure.\n\nMineralocorticoid resistance produces reduced tissue responsiveness despite adequate or elevated hormone concentrations. In these conditions, hormone concentration alone does not establish whether mineralocorticoid action is sufficient."
    },
    {
      "heading": "Pharmacological relevance",
      "text": "Fludrocortisone is a synthetic corticosteroid with strong mineralocorticoid activity. It is used for mineralocorticoid replacement in selected forms of adrenal insufficiency. It also has glucocorticoid activity and is not a purely selective mineralocorticoid.\n\nMineralocorticoid-receptor antagonists—including spironolactone, eplerenone, and finerenone—block receptor signaling rather than reproduce it. Their clinical uses vary by drug and include primary aldosteronism, certain forms of heart failure, hypertension, and specified settings of chronic kidney disease. Because these drugs reduce mineralocorticoid-mediated potassium excretion, elevated blood potassium is an important potential adverse effect."
    }
  ],
  "links": [
    "corticosteroid",
    "hormone",
    "kidney",
    "homeostasis",
    "enzyme",
    "renin-angiotensin-aldosterone-system",
    "gene-expression",
    "cortisol",
    "brain",
    "hypertension",
    "cirrhosis",
    "chronic-kidney-disease"
  ],
  "sources": [],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}